证券代码：300509 证券简称：新美星 投资者关系活动记录表 江苏新美星包装机械股份有限公司 投资者关系活动记录表 第 2 页 共 2 页 | 投资者关系活动 | □特定对象调研 □ 分析师会议 | | --- | --- | | 类别 | □ 媒体采访 √ 业绩说明会 | | | □ 新闻发布会 □ 路演活动 | | | □ 现场参观 | | | □ 其他 （请文字说明其他活动内容） | | 参与单位名称及 | 投资者网上提问 | | 人员姓名 | | | 时间 | 2025 年 5 月 9 日(周五)下午 15:00——17:00 | | 地点 | 公司通过深圳证券交易所"互动易"平台（http://irm.cninfo.com.cn） | | | "云访谈"栏目，采用网络远程的方式召开业绩说明会 | | 上市公司接待人 | 1、董事长何云涛 | | 员姓名 | 2、财务总监陈红 | | | 3、独立董事李苒洲 | | | 4、董事会秘书张钦杰 | | | 投资者提出的问题及公司回复情况 | | | 公司就投资者在本次说明会中提出的问题进行了回复： | | | 1、公司本期的盈利水平如何？ | | | ...

Financial Performance - In 2024, the company achieved total revenue of 2,193.99 million CNY, a growth of 1.03% compared to 2023's 2,171.60 million CNY [1] - The total profit reached 643.94 million CNY, an increase of 24.24% from 518.28 million CNY in the previous year [1] - Net profit attributable to shareholders was 521.53 million CNY, up 23.79% from 421.30 million CNY year-on-year [1] - In Q1 2025, the net profit after deducting non-recurring gains and losses was 97.67 million CNY, reflecting an 11.61% increase from 87.52 million CNY in Q1 2024 [1] Business Development - The biopharmaceutical sector is a key part of the company's dual-wing strategy, facing high investment and long R&D cycles, with current market conditions being challenging [1] - The company is experiencing increased competition and a diverse customer base, leading to some idle capacity in the CDMO supply chain [1] - Ongoing projects in the biopharmaceutical pipeline are still in the R&D phase, with limited revenue from technical services [1] - The company is optimizing costs and personnel structure while focusing on promising projects, such as the BC006 monoclonal antibody injection, which is nearing completion of Phase I clinical trials [1] Inventory and Sales Management - The company has upgraded its inventory management system, utilizing BI analytics to enhance market demand alignment and cost control [2] - The overall inventory level has improved significantly, maintaining a healthy cycle of 1.5 to 2 months, which supports operational quality and cost optimization [2] - The company has implemented diverse promotional activities to stimulate market demand and optimize inventory across channels [2] Product Growth and Dividends - The growth trend for second and third-tier products remains positive, with specific products like the Guaifenesin capsule expected to continue strong growth [2] - The company plans to maintain its cash dividend policy, proposing a distribution of 3.5 CNY per 10 shares, totaling 206 million CNY for 2024 [2] Sales Expense Management - The company has adopted a more precise approach to sales expense allocation, focusing on second and third-tier products while maintaining a low expense ratio for first-tier products [3] - Overall sales expenses are aligned with sales revenue, indicating no significant changes in the sales expense ratio for the year [3]

Group 1: Investor Relations Activities - The investor relations activity was conducted via a network meeting on May 7-8, 2025, with participation from various funds and securities companies [3] - Attendees included major investment firms such as泉果基金, 宝盈基金, and 工银理财 [3] Group 2: Supply Chain and Supplier Relationships - The company maintains stable partnerships with suppliers through annual framework agreements and diverse cooperation models, ensuring a stable supply chain [4] - The company has established supplier channels in major production areas across the country [4] Group 3: Market Demand and Growth Drivers - The demand for konjac powder surged in 2024, driven by the explosion of demand in leisure food, expansion in tea beverage markets, and deeper applications in food processing [5] - The company’s konjac crystal ball products have seen improved profit margins due to optimized processes and collaboration with clients [6] Group 4: Production Capacity - The production capacity for konjac leisure food is 10,000 tons, while the capacity for konjac ingredients is 15,000 tons [7] Group 5: Business Challenges - The konjac ingredient segment faces challenges such as lower profit margins, channel expansion, cost control, and brand establishment [8] Group 6: Future Development Strategy - The company aims to lead the konjac powder industry by focusing on market needs and expanding applications globally [9] - Key strategies include enhancing the capabilities in konjac gum and collaborative gum businesses, developing health food products rich in dietary fiber, and driving sustainable development through innovation [9]

证券代码：001205 证券简称：盛航股份 南京盛航海运股份有限公司投资者关系活动记录表 编号：2025-001 | | □特定对象调研 □分析师会议 | | | | | --- | --- | --- | --- | --- | | 投资者关系 | □媒体采访 □√业绩说明会 | | | | | 活动类别 | □新闻发布会 □路演活动 | | | | | | □现场参观 | | | | | | □其他 （请文字说明其他活动内容） | | | | | 参与单位名 | | | | | | 称及人员姓 | 参与公司 年度暨 2024 2025 | | | 年第一季度网上业绩说明会的投资者 | | 名 | | | | | | 时间 | 2025 年 5 9 日 15:00-16:30 | 月 | | | | 地点 | 价值在线（https://www.ir-online.cn/） 董事长：晏振永 | | | | | | 联席董事长：李桃元 董事兼总经理：李广红 | | | | | 上市公司接 | 独立董事：乔久华 | | | | | 待人员姓名 | 副总经理：刁建明 | | | | | | 副总经理兼董事会秘书：王 ...

| 资源保障，提升对资源端的议价能力，形成成本竞争优 | | --- | | 势。4、有效利用上市公司平台再融资功能，加强资本运 | | 作，为业务增长提供资金支撑，同时降低融资成本，提 | | 高企业效益。 5、针对沥青大宗商品行情波动的特点加 | | 强市场行情分析团队的研判能力，建立专业化期货团 | | 队，利用期货工具平衡市场价格波动风险对公司经营产 | | 生的影响。 | | 2、问：公司 2024 年营业收入同比下降 8.23%，而归属 | | 于上市公司股东的净利润却同比增长 149.91%，实现扭 | | 亏为盈。请问主要原因是什么？ | | 答：感谢您对公司的关注。主要有以下几方面的因素： | | 1、坚定"沥青+通航"两大主营业务发展方向，优化经 | | 营结构深化降本增效；2、优化公司产业结构，合理分配 | | 资源，公司对外出售四川宝利沥青有限公司并出售数架 | | 直升机、相关航材配件及配套服务；3、前期款项的收回。 | | 祝您投资顺利！ | | 3、问：沥青市场在 2024 年整体表现低迷，价格跌幅远 | | 大于原油，导致沥青厂长期处于亏损状态；请问公司如 | | 何预测 20 ...

编号：2025-010 | | □特定对象调研 □分析师会议 | | | | --- | --- | --- | --- | | 投资者关系活动 | □媒体采访 □业绩说明会 | | | | 类别 | □新闻发布会 √路演活动 | | | | | □现场参观 √电话会议 | | | | | □其他： | | | | 参与单位名称及 | 浙商证券、广发证券、东吴证券、贝莱德、中欧基金、银河 基金、华夏基金、中银基金、申万菱信、鹏扬基金、鹏华基 金、汇安基金、中邮创业、平安资产、甬证资管、国寿资产、 | | | | 人员姓名 | 新华资产、国泰人寿、磐泽资本、彤源投资、涌乐投资、翀 | | | | | 云投资、理成资产、正圆投资、宽潭资本、盘京投资、大家 | | | | | 资产等 | | | | 时间 | 2025 年 月 7 日至 2025 年 5 月 9 日 | 5 | | | 地点 | 券商策略会现场、电话会议、基金公司会议室 | | | | 上市公司接待人 | 董事会秘书：朱星毓 | | | | 员姓名 | | | | | | （一） 公司 2024 年度及 2025 年一季度的经营情况如何？ 答复： ...

证券代码：300531 证券简称：优博讯 深圳市优博讯科技股份有限公司 2024年度及2025年第一季度业绩网上说明会 暨投资者关系活动记录表 编号：IR-2025-001 答:2024年研发投入金额为139,206,279.99元，研发投入占营业收入 比例为11.40%，研发投入较去年同期增加12.27%，且连续三年增长。 2024年公司推出搭载紫光展锐UNISOC P7885的全新开源鸿蒙版智能手持 终端DT50 5G，该终端已通过OpenHarmony4.1 Release版本兼容性测评； 公司围绕"AI+AIDC"战略深化技术研发与场景应用，通过融合AI视觉识 别、自然语言处理（NLP）技术升级智能终端，联合国产芯片优化端边云 协同算力架构，并基于边缘计算提升本地化处理效率；公司自主研发的 AI扫描技术可高效识别各类一维/二维码及污损、扭曲码，AI视觉分拣系 统结合区块链技术实现物流全链路可信追溯；在制造领域，AI视觉质检 系统完成纳米级缺陷检测，预测性维护技术减少设备非计划停机时间； 智慧零售场景中，重力传感与AI摄像头实时监测库存，动态生成补货建 议，RFID+AI技术助力连锁餐饮企业实现食材全生 ...

证券代码：870199 证券简称：倍益康 公告编号：2025-044 四川千里倍益康医疗科技股份有限公司 投资者关系活动记录表 本公司及董事会全体成员保证公告内容的真实、准确和完整，没有虚假 记载、误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承 担个别及连带法律责任。 一、 投资者关系活动类别 □特定对象调研 √业绩说明会 □媒体采访 □现场参观 □新闻发布会 □分析师会议 □路演活动 □其他 二、 投资者关系活动情况 三、 投资者关系活动主要内容 1、2024 年公司的业绩表现如何？ 您好，2024 年公司实现营业收入 2.91 亿元，归属于母公司股东的净利润 2,778.14 万元；截至 2024 年 12 月 31 日，公司总资产 6.90 亿元。受宏观经济 环境及消费需求波动影响，收入同比有所下降，公司将持续优化经营策略，积 极布局海外市场与新产品研发，努力提升业绩水平。谢谢！ 2、公司在 2024 年新增的固定资产主要用于哪些业务领域？这些投资对未 来的业绩增长有何预期影响？ 您好，公司 2024 年新增固定资产主要包括以下两个方面，一是购置与生 产经营相关的生产设备，另外则是公司为拓 ...

Group 1: Investor Relations Activities - The company conducted investor relations activities including specific object research and performance briefings from May 7 to May 8, 2025 [3] - Participants included various securities and asset management firms, with key company representatives present [3] Group 2: Sales and Market Strategy - The company is optimizing its e-commerce operations but cannot disclose specific sales growth rates due to lack of data from platforms [4] - The company plans to enhance marketing efforts for its sub-brand, 康食季, to improve product visibility [5] - There are no current plans to expand overseas sales channels, but the company is focusing on building a physical sales network [6] Group 3: Product Development and Innovation - The company is exploring the development of non-sport beverages and plans to launch a new sports drink, focusing on taste and packaging improvements [6] - The company has signed military supply orders for 2024, which will be executed in 2025, with military products accounting for approximately 10% of revenue [8] - The company is investing 100 million yuan in expanding its production capacity for sports nutrition products [9] Group 4: Financial Performance and Management - Accounts receivable increased due to military sales, while inventory rose to ensure business continuity [10] - The company aims to enhance gross margins through technological innovation and supply chain optimization [11] - The company has 198 authorized patents, with significant advancements in product development, including a new high-quality protein product [20] Group 5: Social Responsibility and Community Engagement - The company launched the "Public Energy Rabbit" initiative to support runners in marathons, participating in nearly 470 events in 2024 [14] - Future plans include expanding social responsibility projects and promoting sports nutrition knowledge in communities [15] Group 6: Market Trends and Regulatory Environment - The health and sports nutrition industry is experiencing growth due to government policies promoting health consumption and sports participation [21] - The company plans to establish four product project teams targeting protein supplementation, energy products, weight control, and professional sports markets [22] Group 7: Profitability and Operational Efficiency - The company is focused on high-quality operations, with improved inventory turnover from 2.34 in 2022 to 3.02 in 2024 [23] - The accounts receivable turnover increased from 9.5 in 2022 to 14.84 in 2024, indicating enhanced operational efficiency [23]

1 | | 天风证券 李璇 | | --- | --- | | | 华安基金 孔涛 | | | 申万菱信 黄书瀚 | | 时间 | 2025 年 5 月 9 日 | | 地点 | 公司会议室 | | 上市公司接待 | 董事长兼总经理孙松鹤、董事兼副总经理吴长峰、副总经理兼董事会 | | 人员姓名 | 秘书许恬 | | | 一、介绍环节 | | | 公司副总经理兼董事会秘书许恬就公司 年度及 年一季 2024 2025 | | | 度经营情况做了介绍。 | | | 二、问答环节 | | | 1、曼卡龙的优势是什么？在未来可能出现的困难及挑战？ | | | 答：我们核心优势在于线上化的能力，未来线下门店的运营想要突破 | | | 半径，就得借助强大的线上运营能力，所以这里最大、最重要的挑战 | | | 是对加盟商的筛选，我们需要能感知年轻消费者的需求，懂得如何线 | | | 上线下相结合进行运营的加盟商。 | | | 2、如何做符合年轻人喜好的产品？ | | | 答：在产品研发时，我们注重对消费者的研究，且要关注国际时尚资 | | 投资者关系活动 | 讯，将前沿的流行趋势融入设计，所以公司产品一定是从中国文化出 ...